Chest Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
COPYRIGHT © 2005 by the American College of Chest Physicians.
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bueno, R.
Right arrow Articles by Weisberg, O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bueno, R.
Right arrow Articles by Weisberg, O.

Late-Breaking Science


Tuesday, November 1, 2005

12:30 PM - 2:00 PM

FLEXIBLE DELIVERY OF CARBON DIOXIDE LASERS THROUGH THE OMNIGUIDE PHOTONIC BANDGAP FIBER FOR TREATMENT OF AIRWAY OBSTRUCTION: SAFETY AND FEASIBILITY STUDY

Raphael Bueno, John Godleski, Jeanne M Lukanich, David Feller-Kopman, Aaron Micetich, David S. Torres, Baruch Schori, Gil Shapira and Ori Weisberg

Brigham and Women’s Hospital, Boston, MA

PURPOSE: To investigate the safety and feasibility of Carbon Dioxide (CO2) laser transmission through the OmniGuide Photonic Bandgap Fiber (OPBF) for treatment of airway obstruction.

METHODS: Experiments using discarded human lung tumor tissue were carried out to determine the therapeutic dose for effective tumor destruction. Laser bronchoscopy was performed on 20 sheep to examine the safety and feasibility of the proposed treatment algorithm (dosages 3W to 10W). Animals were euthanized at 1 week and 4 weeks for pathological examination.

RESULTS: A dose response with the maximal thermal effect at the highest dose was observed. Microscopically, the maximal depth of penetration (0.5mm) was obtained only with the high dose at the shortest distance (10W, 5mm). The thermal effect to non-targeted tissue was minimal. Animal experiments demonstrated ease in maneuverability and flexibility of the procedure. Distal airways were easily accessible with the fiber. Tissue damage was highly localized and visible, facilitating a very high degree of control over penetration, ablation and cutting. No laser-related complications were observed. Application of maximal dosage (10 Watts) did not result in perforation, bleeding or other injuries. Four incidents of mild bleeding were easily and immediately controlled with laser shots at the high dosage setting.

CONCLUSION: The CO2 laser delivered through the OPBF can supply an effective dose for tumor destruction. The same dosages can be applied via flexible bronchoscopy safely in airways of live animals. Depth of penetration can be controlled by altering output power or distance from the target tissue. In no case was the penetration deeper than the superficial cartilage.

CLINICAL IMPLICATIONS: This is the first reported CO2 laser delivery through a standard flexible bronchoscope for ablative therapy in the distal airways. CO2 laser transmission through the OPBF may potentially provide a more controllable and precise modality for treatment of benign and malignant airway lesions. This precision is likely to make laser therapy safer and applicable to more lesions. Moreover, potential exists for superficial mucosal ablation of carcinoma in-situ.

DISCLOSURE: Raphael Bueno, None.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.